Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-17-005883
Filing Date
2017-03-01
Accepted
2017-03-01 21:04:15
Documents
1
Period of Report
2016-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4237
  Complete submission text file 0000899243-17-005883.txt   5594
Mailing Address 2400 BAYSHORE PARKWAY SUITE 200 MOUNTAIN VIEW CA 94043
Business Address
GIANAKAKOS ANASTASIOS (Reporting) CIK: 0001413822 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37609 | Film No.: 17656719

Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Issuer) CIK: 0001552451 (see all company filings)

EIN.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations